Skip to main content
SpringerLink
Log in

Gli effetti del lanreotide sulla captazione del 68Ga-DOTATATE nei pazienti con tumore neuroendocrino: una valutazione intra-paziente prospettica

  • NOVITÀ IN ENDOCRINOLOGIA
  • Published:
L'Endocrinologo Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Bibliografia

  1. Cescato R, Schulz S, Waser B et al. (2006) Internalization of sst 2, sst 3, and sst 5 receptors: effects of somatostatin agonists and antagonists. J Nucl Med 47:502–511

    CAS  PubMed  Google Scholar 

  2. De Jong M, Breeman WA, Bernard BF et al. (1999) Tumor uptake of the radiolabeled somatostatin analog [DOTA-0, Tyr-3] octreotide is dependent on the peptide amount. Eur J Nucl Med 26:693–698

    Article  Google Scholar 

  3. Haug AR, Rominger A, Mustafa M et al. (2011) Treatment with octreotide does not reduce tumor uptake of 68 Ga-DOTATATE as measured by PET/CT in patients with neuroendocrine tumors. J Nucl Med 52:1679–1683

    Article  CAS  Google Scholar 

  4. Ayati N, Lee ST, Zakavi SR et al. (2017) Long-acting somatostatin analog therapy differentially alters 68Ga-DOTATATE uptake in normal tissues compared to primary tumors and metastatic lesions. J Nucl Med 59:223–227

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento di Medicina Sperimentale, Sapienza Università di Roma, Roma, Italia

    Valentina Di Vito & Antongiulio Faggiano

Authors
  1. Valentina Di Vito
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Antongiulio Faggiano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Antongiulio Faggiano.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Di Vito, V., Faggiano, A. Gli effetti del lanreotide sulla captazione del 68Ga-DOTATATE nei pazienti con tumore neuroendocrino: una valutazione intra-paziente prospettica. L'Endocrinologo 21, 66–67 (2020). https://doi.org/10.1007/s40619-020-00663-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40619-020-00663-w

Search

Navigation